-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In early October 2020, researchers isolated the mutant strain B.
Coronavirus disease
Recently, researchers investigated the mortality of patients caused by VOC 202012/1 variant infection.
Recently, researchers investigated the mortality of patients caused by VOC 202012/1 variant infection.
Researchers collected data on 54906 patients with new coronary pneumonia infection.
The study found that among patients who tested positive for the new coronavirus in the community , the risk ratio of mortality associated with VOC 2020212/1 mutant virus infection was 1.
Compared with patients with uninfected mutant strains, the risk ratio of mortality associated with VOC 2020212/1 mutant virus infection is 1.
The study found that the risk of death in patients caused by the British new coronary pneumonia VOC-202012/01 variant strain increased by 64% .
The risk of death in patients caused by the British new coronary pneumonia VOC-202012/01 variant increased by 64%
Original source:
Original source:Harriet Forbes et al.
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.
Leave a message here
